SCHEMBL19082291

SCHEMBL19082291

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5c6sc7cc8ccccc8cc7c6cc6sc7ccccc7c56)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.35
MAPT P10636 3/20 0.32
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
GPR3 P46089 1/20 0.31
NQO1 P15559 1/20 0.31
NQO2 P16083 1/20 0.31
S1PR4 O95977 1/20 0.31
S1PR5 Q9H228 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TNKS O95271 1/20 0.30
TNKS2 Q9H2K2 1/20 0.30
ALOX5 P09917 1/20 0.30
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
DUSP3 P51452 1/20 0.30
BLM P54132 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945714 0.94 PTPN1 (0.37) PTPN1MAPTESR1ESR2GPR3
SCHEMBL19082381 0.90 ALOX5 (0.34) PTPN1NQO1NQO2S1PR4S1PR5
SCHEMBL19082203 0.90 PTPN1 (0.35) PTPN1MAPTESR1ESR2TNKS
SCHEMBL17945271 0.89 TNKS (0.36) PTPN1MAPTGPR3NQO1NQO2
SCHEMBL17945011 0.89 PTPN1 (0.37) PTPN1MAPTESR1ESR2GPR3
SCHEMBL17945725 0.89 TNKS (0.40) PTPN1MAPTESR1ESR2GPR3
SCHEMBL18268645 0.88 TNKS (0.39) PTPN1MAPTESR1ESR2GPR3
SCHEMBL19082099 0.88 ESR1 (0.38) PTPN1MAPTESR1ESR2GPR3
SCHEMBL19082331 0.84 PTPN1 (0.36) PTPN1MAPTESR1ESR2GPR3
SCHEMBL17945683 0.84 HSD17B1 (0.35) PTPN1MAPTESR1ESR2GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PTPN1 4695/4885MAPT 1294/4885ESR1 225/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PTPN1 4695/4885MAPT 1294/4885ESR1 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.